Patients with Malabsorption Disorders Patients with GI conditions like Crohns, celiac disease, or atrophic gastritis may struggle to absorb dietary or standard oral B12
definitely sticking with these guys
As of March 2026, BPC-157 has transitioned into an "investigational clinical staple," backed by a series of foundational safety trials and specialized pilot studies
The enthusiasm surrounding these molecules both the naturally occurring kind as well as the synthetic variety is that they can be engineered to target specific biological processes involved in tissue regeneration, bone healing, gut health and sexual function, among many others
[DOI] [PMC free article] [PubMed] [Google Scholar] 55.Gimm T, Wiese M, Teschemacher B, Deggerich A, Schodel J, Knaup KX, et al